Jan 01,2019

Lunit Grabs $4 Million from Fujifilm

Lunit, a leading medical artificial intelligence (AI) company providing solutions for precision diagnostics and therapeutics, announced today that it has raised $26M in its series C funding. This round was backed by Asian investors, led by Korea’s Shinhan Investment, followed by InterVest, IMM Investment, Kakao Ventures, and China’s Legend Capital of Lenovo Group. The funding round is the latest after the Fujifilm investment of $4.3M and Series B funding of $15M last year. Founded in 2013, Lunit has since raised $50M in total.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 17,2019

TrialJectory Raises $3 Million in Seed Financing Round

TrialJectory (known as Leal Health now), an AI-powered technology platform that uses self-reported clinical data to match cancer patients with clinical trials and remove barriers to advanced treatment options, announced today that the Company has closed a $2.7 million seed financing round, led by Contour Venture Partners. Proceeds from the financing will expedite the growth of TrialJectory's platform, which includes adding more clinical trials for different cancer types and expanding the Company's outreach across the medical, pharmaceutical and patient communities. 

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Feb 07,2022

Trialjectory Raises $20 Million to Transform the Cancer Care Industry

Trialjectory (now known as Leal Health), the AI-powered decision-support platform for patients, healthcare providers and pharma, announced that it has raised  $20 million in a Series A round led by New York-based global private equity and venture capital firm Insight Partners, with participation from new investor JAL Ventures and from existing investors Contour Venture Partners, Rho Capital and TIA Ventures. Trialjectory will use the funding to transform cancer care by defining a new market category focused on delivering personalized, treatment decision-support and a new way for pharma to offer an authentic, patient-centered experience.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Oct 04,2023

Smileyscope Closes Seed Prime Round

Smileyscope, an Austin, TX-based company advancing digital therapeutics, raised an undisclosed amount in Seed Prime funding. The round included investments from Breakthrough Victoria, Ten13, Alice Anderson Fund and MedAngels. The company intends to use the funds to grow its clinical-stage pipeline, and expand across the health systems in the United States and Australia.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 19,2023 TOP STORY

Outcomes4Me Announces Investments to Accelerate Life-Saving Treatments for Cancer Patients

 Outcomes4Me Inc., the developer of the direct-to-patient, personalized and evidence-based cancer navigation platform, announced today it has entered into two innovative collaborations and investment structures, which together combine artificial intelligence (AI) technology, treatment awareness and education, diagnostic testing access and mass media to help more patients with cancer. Through an equity investment and collaboration agreement with Labcorp, Outcomes4Me aims to improve patient outcomes by novel precision oncology treatment options through information about and access to specialty biomarker testing, including comprehensive genomic profiling, offered by Labcorp. Additionally, Outcomes4Me and Forecast Labs, a division of Comcast NBCUniversal, have entered into an earned equity investment arrangement to provide access to performance-based TV advertising to accelerate patient acquisition for Outcomes4Me. 

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 23,2021

Danish medtech startup Hedia raises €3 million and plans European expansion

Medtech startup from Copenhagen, Hedia, has just raised an additional €3 million for its technology to manage diabetes. The company is backed by Novo-heirs, and we reckoned it was one to watch back in 2019.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jul 01,2019

Hedia secured $2.3M in fresh new capital funding

Hedia, a Copenhagen, Denmark-based startup providing a digital solution for people suffering from diabetes, completed a DKK 15M ($2.3M) capital investment round. The funding was provided by Danish investors and will be used to support the company's expansion in the US market, expected in 2020.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 21,2016

Green light for intelligent diabetes app Hedia

Hedia has landed its first investment of half a million kroner, which over the next few months will turn the startup's idea into a fully functional product. The investment is a so-called Discovery loan from PSI/SEED, which is a strategic collaboration between the innovation environment Pre-Seed Innovation and SEED Capital .

FUNDING CONVERTIBLE NOTE
View Analyst & Ambassador Comments
Go to original news
Sep 11,2023 TOP STORY

Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital

Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has entered into a $50 million loan facility with Hercules Capital, Inc. The company also announced it drew down $25 million upon the transaction closing.

FUNDING LOAN FACILITY
View Analyst & Ambassador Comments
Go to original news
Aug 22,2023

Value-based oncology platform Thyme Care clinches $60M to expand in new markets

Thyme Care, a value-based oncology platform, has raised $60 million in a series B round. The round was co-led by Town Hall Ventures and Foresite Capital with participation from existing investors Andreessen Horowitz Bio + Health, AlleyCorp, Casdin Capital and Frist Cressey Ventures. The funding will be used to accelerate partnerships in new markets and expand its cancer care support services. Thyme Care also plans to broaden its roster of oncology and healthcare experts and announce additional partnerships in the coming months. The latest capital brings the company’s total raised to more than $80 million. Thyme Care combines tech with high-touch patient care to support care journeys. Powered by a team of nurse practitioners, oncology nurses and resource specialists, the company aims to help members better understand their diagnosis, manage and address symptoms and quickly connect them to care with its platform, Thyme Box.

FUNDING SERIES B

#virtual care

View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING